Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis

BACKGROUND: The therapy of visceral leishmaniasis (VL) is limited by resistance, toxicity and decreased bioavailability of the existing drugs coupled with dramatic increase in HIV-co-infection, non-availability of vaccines and down regulation of cell-mediated immunity (CMI). Thus, we envisaged comba...

Descripción completa

Detalles Bibliográficos
Autores principales: Islamuddin, Mohammad, Chouhan, Garima, Want, Muzamil Yaqub, Ozbak, Hani A., Hemeg, Hassan A., Afrin, Farhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077126/
https://www.ncbi.nlm.nih.gov/pubmed/27776125
http://dx.doi.org/10.1371/journal.pntd.0005011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077126/
https://www.ncbi.nlm.nih.gov/pubmed/27776125
http://dx.doi.org/10.1371/journal.pntd.0005011

Ejemplares similares